FR3121043B1 - Composition antioxydante stabilisee par un filtre uva organique - Google Patents

Composition antioxydante stabilisee par un filtre uva organique Download PDF

Info

Publication number
FR3121043B1
FR3121043B1 FR2103167A FR2103167A FR3121043B1 FR 3121043 B1 FR3121043 B1 FR 3121043B1 FR 2103167 A FR2103167 A FR 2103167A FR 2103167 A FR2103167 A FR 2103167A FR 3121043 B1 FR3121043 B1 FR 3121043B1
Authority
FR
France
Prior art keywords
uva filter
antioxidant
organic
stabilized
antioxidant composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2103167A
Other languages
English (en)
Other versions
FR3121043A1 (fr
Inventor
Nicholas David Stebbins
Chirch Susan Halpern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR2103167A priority Critical patent/FR3121043B1/fr
Priority to PCT/IB2022/050019 priority patent/WO2022149055A1/fr
Publication of FR3121043A1 publication Critical patent/FR3121043A1/fr
Application granted granted Critical
Publication of FR3121043B1 publication Critical patent/FR3121043B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Composition antioxydante stabilisée par un filtre UVA organique Un système antioxydant stabilisé par filtre UVA organique démontre une stabilisation après une exposition aux UV par rapport à des témoins dépourvus du filtre UVA stabilisateur. Le système antioxydant stabilisé par filtre UVA fournit une composition cosmétique qui confère une efficacité antioxydante préservée et durable à un tissu kératineux. Le système antioxydant inclut une combinaison d’au moins un dérivé d’hydroxycinnamate et d’un filtre UVA hydrosoluble organique dans un support à base d’eau. Figure pour l’abrégé : Néant
FR2103167A 2021-01-05 2021-03-29 Composition antioxydante stabilisee par un filtre uva organique Active FR3121043B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR2103167A FR3121043B1 (fr) 2021-03-29 2021-03-29 Composition antioxydante stabilisee par un filtre uva organique
PCT/IB2022/050019 WO2022149055A1 (fr) 2021-01-05 2022-01-03 Composition antioxydante stabilisée par un filtre uva organique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2103167A FR3121043B1 (fr) 2021-03-29 2021-03-29 Composition antioxydante stabilisee par un filtre uva organique
FR2103167 2021-03-29

Publications (2)

Publication Number Publication Date
FR3121043A1 FR3121043A1 (fr) 2022-09-30
FR3121043B1 true FR3121043B1 (fr) 2024-03-08

Family

ID=75690593

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2103167A Active FR3121043B1 (fr) 2021-01-05 2021-03-29 Composition antioxydante stabilisee par un filtre uva organique

Country Status (1)

Country Link
FR (1) FR3121043B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140043A (en) 1989-04-17 1992-08-18 Duke University Stable ascorbic acid compositions
FR2932679B1 (fr) * 2008-06-24 2010-08-27 Oreal Utilisation de l'acide ferulique ou ses derives pour ameliorer l'etat de surface d'une peau alteree.
FR3034987B1 (fr) * 2015-04-15 2018-08-24 L'oreal Composition a base de trans-resveratrol ou d'un derive de trans-resveratrol
US10729633B2 (en) * 2018-03-29 2020-08-04 L'oreal Methods for boosting UVA photo-protection using antioxidants

Also Published As

Publication number Publication date
FR3121043A1 (fr) 2022-09-30

Similar Documents

Publication Publication Date Title
MX2021002230A (es) Formulaciones en emulsion de inhibidores de multicinasa.
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
PE20180160A1 (es) Sulfonilureas y compuestos relacionados y uso de estos
CL2011000222A1 (es) Uso de una composicion que contiene a) quitosano o hidroxipropil quitosano, b) al menos un ingrediente seleccionado de inhibidores de alfa-5-reductasa, hormonas antiandrogenicas, agonistas del canal de potasio y extractos vegetales, c) etanol o isopropanol, para el tratamiento o prevencion de afecciones del cabello o cuero cabelludo tales como caida del cabello, alopecia, alopecia androgenica, entre otras.
ATE432740T1 (de) Stabilisierte ascorbinsäure-zusammensetzungen und verfahren dafür
CL2023001738A1 (es) Inhibidores de prmt5
ATE420625T1 (de) Intravenöse propofol-emulsionszusammensetzungen mit konservierendem effekt
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
ES2811132T3 (es) Composición antimicrobianamente eficaz estabilizada con un contenido de octenidina
ECSP088558A (es) Carbonilamino pirrolopirazoles, potentes inhibidores de quinasa
BR112021002069A2 (pt) Composição para tratamento capilar, métodos e usos da mesma.
AR048748A1 (es) Concentrados en suspension de base oleaginosa
EA200702636A1 (ru) Способ и неокклюзивная композиция для трансдермальной доставки лекарственного средства
CR20190332A (es) Inhibidores selectivos de jak1
CL2021002447A1 (es) (divisional de solicitud 2218-2019) formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
AR124547A1 (es) Degradadores de irak y sus usos
FR3121043B1 (fr) Composition antioxydante stabilisee par un filtre uva organique
CL2022000725A1 (es) Inhibidor de irak y método de preparación para el mismo y uso del mismo
CL2023000491A1 (es) Composiciones de erenumab y usos de las mismas (divisional de solicitud n° 02519-2020).
FR3109307A1 (fr) Désinfectant cutané
CY1123706T1 (el) Οφθαλμικες συνθεσεις που περιεχουν προσταμιδη που απελευθερωνουν μονοξειδιο του αζωτου
MA50116A1 (fr) Agent d'absorption transdermique comprenant du donépézil pour le traitement de la démence
PE20190149A1 (es) Composiciones y metodos para estabilizar alfavirus con formulaciones mejoradas
EA202091736A1 (ru) Применение колхицина для ингибирования роста опухоли и метастазов
CO2023000239A2 (es) Excipientes reductores de viscosidad y combinaciones de los mismos para formulaciones de proteína altamente concentradas

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20220930

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4